Keck ME - Search Results

1

Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.

Keck ME, Wigger A, Welt T, Müller MB, Gesing A, Reul JM, Holsboer F, Landgraf R, Neumann ID. Keck ME, et al. Neuropsychopharmacology. 2002 Jan;26(1):94-105. doi: 10.1016/S0893-133X(01)00351-7. Neuropsychopharmacology. 2002. PMID: 11751036

2

Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model.

Keck ME, Welt T, Müller MB, Uhr M, Ohl F, Wigger A, Toschi N, Holsboer F, Landgraf R. Keck ME, et al. Neuropsychopharmacology. 2003 Feb;28(2):235-43. doi: 10.1038/sj.npp.1300040. Epub 2002 Jul 25. Neuropsychopharmacology. 2003. PMID: 12589376

3

ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder.

Müller MB, Keck ME, Binder EB, Kresse AE, Hagemeyer TP, Landgraf R, Holsboer F, Uhr M. Müller MB, et al. Among authors: keck me. Neuropsychopharmacology. 2003 Nov;28(11):1991-9. doi: 10.1038/sj.npp.1300257. Neuropsychopharmacology. 2003. PMID: 12888779

4

Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice.

Müller MB, Uhr M, Holsboer F, Keck ME. Müller MB, et al. Among authors: keck me. Neuroendocrinology. 2004 Jan;79(1):1-12. doi: 10.1159/000076041. Neuroendocrinology. 2004. PMID: 14755129 Review.

5

Mouse mutants for the study of corticotropin-releasing hormone receptor function: development of novel treatment strategies for mood disorders.

Keck ME, Holsboer F, Müller MB. Keck ME, et al. Ann N Y Acad Sci. 2004 Jun;1018:445-57. doi: 10.1196/annals.1296.055. Ann N Y Acad Sci. 2004. PMID: 15240401 Review.

6

Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders.

Keck ME, Ohl F, Holsboer F, Müller MB. Keck ME, et al. Neurosci Biobehav Rev. 2005;29(4-5):867-89. doi: 10.1016/j.neubiorev.2005.03.003. Neurosci Biobehav Rev. 2005. PMID: 15899517 Review.

7

Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress.

Welt T, Engelmann M, Renner U, Erhardt A, Müller MB, Landgraf R, Holsboer F, Keck ME. Welt T, et al. Among authors: keck me. Neuropsychopharmacology. 2006 Dec;31(12):2573-9. doi: 10.1038/sj.npp.1301006. Epub 2006 Jan 4. Neuropsychopharmacology. 2006. PMID: 16395302

8

Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats.

Hatzinger M, Wotjak CT, Naruo T, Simchen R, Keck ME, Landgraf R, Holsboer F, Neumann ID. Hatzinger M, et al. Among authors: keck me. J Endocrinol. 2000 Feb;164(2):197-205. doi: 10.1677/joe.0.1640197. J Endocrinol. 2000. PMID: 10657855

9

Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats.

Keck ME, Hatzinger M, Wotjak CT, Landgraf R, Holsboer F, Neumann ID. Keck ME, et al. Eur J Neurosci. 2000 Apr;12(4):1487-94. doi: 10.1046/j.1460-9568.2000.00030.x. Eur J Neurosci. 2000. PMID: 10762376

10

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.

Keck ME, Welt T, Wigger A, Renner U, Engelmann M, Holsboer F, Landgraf R. Keck ME, et al. Eur J Neurosci. 2001 Jan;13(2):373-80. doi: 10.1046/j.0953-816x.2000.01383.x. Eur J Neurosci. 2001. PMID: 11168542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters